R&D Insights
Practical writing on Act 60-2019, the §3030.01 research credit, and the sectors driving development activity on the island — life sciences, aerospace and defense, advanced manufacturing, technology and energy.
Holding a grandfathered pre-2019 decree feels safe. Sometimes it is, and sometimes it is quietly costing you. How to tell which situation you are in.
Read articleIf you are the internal champion for an island expansion, these are the questions coming. Prepared answers, including the ones that are uncomfortable.
Read articleCDMOs and contract manufacturers have been expanding on the island while everyone watched the big brands. Why the model fits here, and where the development work sits.
Read articleA straight look at the cost lines that genuinely differ from a mainland project, the ones that do not, and the two that companies consistently underestimate.
Read articleThe decree process is less mysterious than it looks, but the sequencing matters more than most companies expect. A practical walk through what the application involves.
Read articleDevice manufacturers have been concentrating on the island for decades. Here is what that density actually does for a company considering a move, and where the development work sits.
Read articleThe island's pharmaceutical industry contracted, then rebuilt around something different. What changed, and why the current phase is more durable than the one before it.
Read articleMost credit claims fail on evidence rather than eligibility. A practical system for capturing research activity while it is happening, built for teams that are busy.
Read articleCertified credits are transferable, which makes them an asset rather than just a tax position. What drives the price, and what a seller controls.
Read articleThe island is not going to host leading-edge fabrication. Packaging, test and specialized electronics are a different conversation, and a more realistic one.
Read articleThe difference between a Puerto Rico plant that executes and one that develops is bigger than it looks, operationally and financially. Here is how companies make the shift.
Read articleAerospace suppliers have been building real engineering capability in Puerto Rico for years without much fanfare. Here is why the island works for this sector and where it goes next.
Read articleA major pharmaceutical investment on the island is not just a headline. Read it as a signal about biologics, reshoring, and where development work is heading.
Read articleThe island's infrastructure challenges have turned it into a live testing ground for grid, storage, and water technology. That is an R&D opportunity hiding inside a problem.
Read articleFor a European or Asian company that needs a United States presence, Puerto Rico offers a combination that is hard to find anywhere else. A look at why that decision keeps getting made.
Read articleA practical look at how pharmaceutical, biotech, device, and diagnostics development work maps to the Puerto Rico research credit, with the gray areas called out honestly.
Read articleThe credit is generous and the rules are workable. Most of the damage we see comes from avoidable mistakes made in the first year. Here are the ones worth knowing about.
Read articlePuerto Rico has quietly rebuilt itself into a serious research and development base. Here is what is actually driving it, and what it means for companies weighing an expansion.
Read articleThe most common objection to an island expansion is people. A direct look at the engineering and science workforce, where it is deep, where it is thin, and how companies hire well.
Read articleDomestic production has gone from a talking point to a procurement requirement. Puerto Rico sits in a uniquely advantaged position, with some real constraints worth naming.
Read articleTechnology companies rarely think about the island, which is exactly why the opportunity is interesting. A practical look at software development, AI, and cybersecurity work in Puerto Rico.
Read article